Gynecologic oncology
Publication date:
2013-09-01
Volume:
130
Pages:
636 -
41
Publisher:
Academic Press
Author:
Monk, Bradley J
Lambrechts, Sandrina ; Minion, Lindsey ; Devoogdt, Nele ; Karlan, Beth Y ; Vergote, Ignace
Keywords:
Science & Technology, Life Sciences & Biomedicine, Oncology, Obstetrics & Gynecology, Trebananib, AMG 386, Edema, Ovarian cancer, Anti-angiogenic agent, ADVANCED SOLID TUMORS, ANGIOPOIETIN 1/2-NEUTRALIZING PEPTIBODY, DOUBLE-BLIND, OVARIAN-CANCER, PHASE-II, COMBINATION, ANGIOGENESIS, BEVACIZUMAB, CHEMOTHERAPY, CARCINOMA, Angiogenesis Inhibitors, Carcinoma, Ovarian Epithelial, Female, Humans, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Recombinant Fusion Proteins, 1112 Oncology and Carcinogenesis, 1114 Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, 3202 Clinical sciences, 3211 Oncology and carcinogenesis, 3215 Reproductive medicine